Selection of appropriate serological tests to measure the incidence of natural Leishmania infantum infection during DNA/MVA prime/boost canine vaccine trials

Veterinary Parasitology

Volumn 162, Issue 3-4, 2009, Pages 207-213

  Carson, Connor ^a   Antoniou, Maria ^b   Christodoulou, Vasiliki ^b   Messaritakis, Ippokratis ^b   Quinnell, Rupert J ^c   Blackwell, Jenefer M ^d   Courtenay, Orin ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF CRETE   (Greece)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Dogs; Epidemiology; Leishmania infantum; Prime boost vaccination; Serology; Visceral leishmaniasis

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G; PEROXIDASE; RECOMBINANT ANTIGEN; RK39 ANTIGEN; TRYPAREDOXIN PEROXIDASE; UNCLASSIFIED DRUG; VACCINIA VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INNATE IMMUNITY; LEISHMANIA INFANTUM; LEISHMANIASIS; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; SEROCONVERSION; SEROLOGY;

ANIMALS; ANTIBODIES, PROTOZOAN; BRAZIL; DOG DISEASES; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GREECE; LEISHMANIA INFANTUM; LEISHMANIASIS VACCINES; LEISHMANIASIS, VISCERAL; MALE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VACCINES, DNA; VACCINIA VIRUS;

CANIS FAMILIARIS; LEISHMANIA INFANTUM; VACCINIA VIRUS ANKARA;

EID: 67349235546     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2009.03.037     Document Type: Article

References (51)

1. Abranches P., Lopes F.J., Silva F.M., Ribeiro M.M., and Pires C.A. Kala-azar in Portugal. III. Results of a survey on canine leishmaniasis performed in the Lisbon region. Comparison of urban and rural zones (Article in French). Ann. Parasitol. Hum. Comp. 58 (1983) 307-315
2. Acedo-Sanchez C., Morillas-Marquez F., Sanchiz-Marin M.C., and Martin-Sanchez J. Changes in antibody titres against Leishmania infantum in naturally infected dogs in southern Spain. Vet. Parasitol. 75 (1998) 1-8
3. Andrade R.A., Silva Araújo M.S., Reis A.B., Gontijo C.M.F., Vianna L.R., Mayrink W., and Martins-Filho O.A. Advances in flow cytometric serology for canine visceral leishmaniasis: diagnostic applications when distinct clinical forms, vaccination and other canine pathogens become a challenge. Vet. Immunol. Immunop. 128 (2008) 79-86
4. Borja-Cabrera G.P., Pontes N.N.C., da Silva V.O., de Souza E.P., Santos W.R., Gomes E.M., Luz K.G., Palatnik M., and de Sousa C.B.P. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN). Vaccine 20 (2002) 3277-3284
5. Burns Jr. J.M., Shreffler W.G., Benson D.R., Ghalib H.W., Badaro R., and Reed S.G. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc. Natl. Acad. Sci. USA 90 (1993) 775-779
6. Carson C., Antoniou M., Alcami A., Ruiz-Argüello M.B., Christodoulou V., Messaritakis I., Blackwell J.M., and Courtenay O. A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis. Vaccine 27 (2009) 1080-1086
7. Cohen J. Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit. Psychol. Bull. 70 (1968) 213-220
8. Courtenay O., Quinnell R.J., Garcez L.M., Shaw J.J., and Dye C. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J. Infect. Dis. 186 (2002) 1314-1320
9. Courtenay O., Quinnell R.J., Garcez L.M., and Dye C. Low infectiousness of a wildlife host of Leishmania infantum: the crab-eating fox is not important for transmission. Parasitology 125 (2002) 407-414
10. da Silva E.S., van der Meide W.F., Schoone G.J., Gontijo C.M.F., Schallig H.D.F.H., and Brazil R.P. Diagnosis of canine leishmaniasis in the endemic area of Belo Horizonte, Minas Gerais, Brazil by parasite, antibody and DNA detection assays. Vet. Res. Commun. 30 (2006) 637-643
11. Do Rosario E.Y., Genaro O., Franca-Silva J.C., Da Costa R.T., Mayrink W., Reis A.B., and Carneiro M. Evaluation of enzyme-linked immunosorbent assay using crude Leishmania and recombinant antigens as a diagnostic marker for canine visceral leishmaniasis. Mem. Inst. Oswaldo Cruz 100 (2005) 197-203
12. Ferreira E.D.C., de Lana M., Carneiro M., Reis A.B., Paes D.V., Silva E.S.D., Schallig H., and Gontijo C.M.F. Comparison of serological assays for the diagnosis of canine visceral leishmaniasis in animals presenting different clinical manifestations. Vet. Parasitol. 146 (2007) 235-241
13. Fisa R., Gallego M., Castillejo S., Aisa M.J., Serra T., Riera C., Carrio J., Gallego J., and Portus M. Epidemiology of canine leishmaniosis in Catalonia (Spain): the example of the Priorat focus. Vet. Parasitol. 83 (1999) 87-97
14. Gradoni L., and Gramiccia M. Leishmaniosis. OIE Manual of Standards for Diagnostic Tests and Vaccines for Terrestrial Animals (2004), Office International des Epizooties, Paris, France pp. 803-812
15. Gradoni L., Manzillo V.F., Pagano A., Piantedosi D., De Luna R., Gramiccia A., Scalone A., Di Muccio T., and Oliva G. Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals. Vaccine 23 (2005) 5245-5251
16. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
17. Lanotte G., Rioux J.A., Croset H., and Vollhardt Y. Ecology of leishmaniasis in the south of France. IX. Sampling methods in the study of the canine enzootic (Article in French). Ann. Parasitol. Hum. Comp. 53 (1978) 33-45
18. Lasri S., Sahibi H., Sadak A., Jaffe C.L., and Rhalem A. Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes. Vet. Res. 30 (1999) 441-449
19. Lemesre J.L., Holzmuller P., Cavaleyra M., Goncalves R.B., Hottin G., and Papierok G. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23 (2005) 2825-2840
20. Levick M.P., Tetaud E., Fairlamb A.H., and Blackwell J.M. Identification and characterisation of a functional peroxidoxin from Leishmania major. Mol. Biochem. Parasit. 96 (1998) 125-137
21. Mancianti F., Pedonese F., and Poli A. Evaluation of dot enzyme-linked immunosorbent assay (dot-ELISA) for the serodiagnosis of canine leishmaniosis as compared with indirect immunofluorescence assay. Vet. Parasitol. 65 (1996) 1-9
22. Mauricio I.L., Stothard J.R., and Miles M.A. The strange case of Leishmania chagasi. Parasitol. Today 16 (2000) 188-189
23. Mettler M., Grimm F., Capelli G., Camp H., and Deplazes P. Evaluation of enzyme-linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatic and asymptomatic Leishmania infections in dogs. J. Clin. Microbiol. 43 (2005) 5515-5519
24. Mohebali M., Khamesipour A., Mobedi I., Zarei Z., and Hashemi-Fesharki R. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, IR Iran. Vaccine 22 (2004) 4097-4100
25. Moreno J., Nieto J., Masina S., Canavate C., Cruz I., Chicharro C., Carrillo E., Napp S., Reymond C., Kaye P.M., Smith D.F., Fasel N., and Alvar J. Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis. Vaccine 25 (2007) 5290-5300
26. Mougneau E., Altare F., Wakil A.E., Zheng S.C., Coppola T., Wang Z.E., Waldmann R., Locksley R.M., and Glaichenhaus N. Expression cloning of a protective Leishmania antigen. Science 268 (1995) 563-566
27. Oliva G., Scalone A., Manzillo V.F., Gramiccia M., Pagano A., Di Muccio T., and Gradoni L. Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons. J. Clin. Microbiol. 44 (2006) 1318-1322
28. Otranto D., Paradies P., de Caprariis D., Stanneck D., Testini G., Grimm F., Deplazes P., and Capelli G. Toward diagnosing Leishmania infantum infection in asymptomatic dogs in endemic area. Clin. Vaccine Immunol. 16 (2009) 337-343
29. Poot J., Rogers M.E., Bates P.A., and Vermeulen A. Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs. Vet. Parasitol. 130 (2005) 41-53
30. Porrozzi R., Santos da Costa M.V., Teva A., Falqueto A., Ferreira A.L., dos Santos C.D., Fernandes A.P., Gazzinelli R.T., Campos-Neto A., and Grimaldi Jr. G. Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs. Clin. Vaccine Immunol. 14 (2007) 544-548
31. Quinnell R.J., Courtenay O., Davidson S., Garcez L., Lambson B., Ramos P., Shaw J.J., Shaw M.A., and Dye C. Detection of Leishmania infantum by PCR, serology and cellular immune response in a cohort study of Brazilian dogs. Parasitology 122 (2001) 253-261
32. Quinnell R.J., Courtenay O., Garcez L., and Dye C. The epidemiology of canine leishmaniasis: transmission rates estimated from a cohort study in Amazonian Brazil. Parasitology 115 (1997) 143-156
33. Ramiro M.J., Zarate J.J., Hanke T., Rodriguez D., Rodriguez J.R., Esteban M., Lucientes J., Castillo J.A., and Larraga V. Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. Vaccine 21 (2003) 2474-2484
34. Ramos I., Alonso A., Marcen J.M., Peris A., Castillo J.A., Colmenares M., and Larraga V. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response. Vaccine 26 (2008) 333-344
35. Reed S.G., Badaro R., and Lloyd R.M. Identification of specific and cross-reactive antigens of Leishmania donovani chagasi by human infection sera. J. Immunol. 138 (1987) 1596-1601
36. Reithinger R., Quinnell R.J., Alexander B., and Davies C.R. Rapid detection of Leishmania infantum infection in dogs: comparative study using an immunochromatographic dipstick test, enzyme-linked immunosorbent assay, and PCR. J. Clin. Microbiol. 40 (2002) 2352-2356
37. Rioux J.A., Killick-Kendrick R., Leaney A.J., Young C.J., Turner D.P., Lanotte G., and Bailly M. Ecology of leishmaniasis in the south of France. 11. Canine leishmaniasis: successful experimental transmission from dog to dog by the bite of Phlebotomus ariasi Tonnoir, 1921 (Article in French). Ann. Parasitol. Hum. Comp. 54 (1979) 401-407
38. Rogers M.E., Ilg T., Nikolaev A.V., Ferguson M.A.J., and Bates P.A. Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG. Nature 430 (2004) 463-467
39. Rosypal A.C., Troy G.C., Duncan R.B., Zajac A.M., and Lindsay D.S. Utility of diagnostic tests used in diagnosis of infection in dogs experimentally inoculated with a North American isolate of Leishmania infantum infantum. J. Vet. Intern. Med. 19 (2005) 802-809
40. Scalone A., De Luna R., Oliva G., Baldi L., Satta G., Vesco G., Mignone W., Turilli C., Mondesire R.R., Simpson D., Donoghue A.R., Frank G.R., and Gradoni L. Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay. Vet. Parasitol. 104 (2002) 275-285
41. Sideris V., Karagouni E., Papadopoulou G., Garifallou A., and Dotsika E.N. Canine visceral leishmaniasis in the Great Athens area, Greece. Parasite 3 (1996) 125-130
42. Sideris V., Papadopoulou G., Dotsika E., and Karagouni E. Asymptomatic canine leishmaniasis in Greater Athens area, Greece. Eur. J. Epidemiol. 15 (1999) 271-276
43. Solano-Gallego L., Llull J., Osso M., Hegarty B., and Breitschwerdt E. A serological study of exposure to arthropod-borne pathogens in dogs from northeastern Spain. Vet. Res. 37 (2006) 231-244
44. Solano-Gallego L., Llull J., Ramis A., Fernandez-Bellon H., Rodriguez A., Ferrer L., and Alberola J. Longitudinal study of dogs living in an area of Spain highly endemic for leishmaniasis by serologic analysis and the leishmanin skin test. Am. J. Trop. Med. Hyg. 72 (2005) 815-818
45. Solano-Gallego L., Riera C., Roura X., Iniesta L., Gallego M., Valladares J.E., Fisa R., Castillejo S., Alberola J., Ferrer L., Arboix M., and Portus M. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas: evolution in the course of infection and after treatment. Vet. Parasitol. 96 (2001) 265-276
46. StataCorp, 2005. Statistical Software: Release 9.0. College Station, TX: Stata Corporation.
47. Stober C.B., Lange U.G., Roberts M.T.M., Alcami A., and Blackwell J.M. IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J. Immunol. 175 (2005) 2517-2524
48. Stober C.B., Lange U.G., Roberts M.T.M., Alcami A., and Blackwell J.M. Heterologous priming-boosting with DNA and modified vaccinia virus Ankara expressing tryparedoxin peroxidase promotes long-term memory against Leishmania major in susceptible BALB/c Mice. Infect. Immun. 75 (2007) 852-860
49. Talmi-Frank D., Strauss-Ayali D., Jaffe C.L., and Baneth G. Kinetics and diagnostic and prognostic potential of quantitative Western blot analysis and antigen-specific enzyme-linked immunosorbent assay in experimental canine leishmaniasis. Clin. Vaccine Immunol. 13 (2006) 271-276
50. Tijssen P. Practice and Theory of Enzyme Immunoassays. first ed. (1985), Elsevier Science Publishers B.V., Amsterdam p. 549
51. Trotz-Williams L.A., and Trees A.J. Systematic review of the distribution of the major vector-borne parasitic infections in dogs and cats in Europe. Vet. Rec. 152 (2003) 97-105